Implantable cardioverter defibrillator management: an update
| Autor: | Filippo Trevisan, Michele Malagù, Matteo Bertini, Marianna Nardozza, Ottavia Mancuso, Alessandra Ferri |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Arrhythmias 030204 cardiovascular system & hematology NO Sudden cardiac death Prosthesis Implantation 03 medical and health sciences 0302 clinical medicine Implantable cardioverter defibrillator Secondary Prevention medicine Humans Device 030212 general & internal medicine Implantation procedure Intensive care medicine Heart Failure Secondary prevention business.industry ICD Prevention Implantable cardioverter-defibrillator medicine.disease Molecular Medicine Cardiology and Cardiovascular Medicine Defibrillators Implantable Primary Prevention Clinical trial Death Sudden Cardiac Heart failure Medical emergency business |
| Zdroj: | Future Cardiology. 12:673-688 |
| ISSN: | 1744-8298 1479-6678 |
| DOI: | 10.2217/fca-2016-0031 |
| Popis: | Implantable cardioverter defibrillator (ICD) is the cornerstone of primary and secondary prevention of sudden cardiac death. In 35 years of technologic improvement and clinical trials, there has been a continuous increase in implantation rate. Purpose of this review is to point out and discuss every aspect related to actual ICD management, investigating implantation procedure and predischarge care, office and remote monitoring follow-up, diagnostic evaluations, management of patients with suspected therapies or malfunctions, heart failure, surgery, radiotherapy and endoscopic procedures. Also, ICD backface such as infections and other complications will be discussed. Finally, we will focus on interesting future perspectives for this setting of patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|